Cost Curve

One Big Beautiful Bridge: 700K Medicare Beneficiaries Have Opted Into CMS’ Obesity Pilot

And pressure on Europe -- especially Germany -- to raise drug prices intensifies

Brian Reid

Copies of Lilly and Pfizer’s MFN Deals Have Been Released. The Takeaway Is █ █ █ █ █ █ █ █ █ █ █ █ █ █

And South Dakota stopped a bounty program for racoon tails last year. That move saved more money than its new Medicaid MFN deal

Brian Reid

Two Reasons To View Today’s Medicaid Drug-Price News With Skepticism

Brian Reid

MFN Has Been Central to HHS Nominee Klomp’s Current Job at CMS, But Senators Entirely Ignore the Topic

And Census Bureau data shows that nonprofit hospital revenue surged 10% over the past year

Brian Reid

The Ten Questions I Wish Senators Had Asked HHS Deputy Nominee Chris Klomp

Brian Reid

Nineteen States Have Expressed Interest in CMS’ Effort to Bring MFN Prices to Medicaid, WaPo Says

And a spate of stories about how MFN might impact pricing and access overseas

Brian Reid

Analysis Shows How Efforts to Bring MFN Price to Medicare Are Hamstrung by White House Deals

And evidence that the “biosimilar void” has been exaggerated

Brian Reid

More on the Nexus Between 340B Hospitals and Spending on Sports Teams

And new AAM data shows expanding savings from generics and biosimilars

Brian Reid

What Does the ‘B’ Stand for in ‘340B’? ‘Ballpark,’ Maybe

And unpacking Trump administration claims about whether anyone is seeing MFN prices

Brian Reid